Surgical Management of Bilateral Exudative Retinal Detachment Associated with Central Serous Chorioretinopathy

Department of Ophthalmology, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
Korean Journal of Ophthalmology 07/2006; 20(2):131-8. DOI: 10.3341/kjo.2006.20.2.131
Source: PubMed

ABSTRACT To report a case of bilateral bullous exudative retinal detachment in central serous chorioretinopathy (CSC) which was attached by vitrectomy and internal drainage of the subretinal fluid.
A 47-year-old man affected by bilateral atypical CSC with a bullous retinal detachment with subretinal exudate. A fluorescein angiogram (FAG) showed multiple points of leakage and staining of subretinal fibrosis. A tentative diagnosis of Vogt-Koyanagi-Harada (VKH) syndrome was made and the patient was treated with systemic corticosteroids and immunosuppressive agents. However, the subretinal fluid was not absorbed. He was then treated with vitrectomy and internal drainage of subretinal fluid.
The retina was attached successfully in both eyes. Visual acuity improved to 20/50 in his left eye but did not improve in the right eye due to subretinal fibrotic scarring and atropic changes on the macula.
Our case suggests that the surgical management of bullous exudative retinal detachment is safe and necessary.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Any patient with a diagnosis of central serous chorioretinopathy (CSCR) should be questioned to determine any recent corticosteroid use, as the poor visual outcome may be due to unrecognized corticosteroid use. Atypical forms of CSCR may be misdiagnosed as an inflammatory serous retinal detachment, mainly Vogt-Koyanagi-Harada disease. CSCR that develops in association with preexisting uveitis could be a challenging diagnosis as it might be misinterpreted as a worsening of the primary inflammatory condition. Failure to differentiate CSCR from retinal or choroidal inflammatory diseases may result in inappropriate use of corticosteroids, leading to exacerbation of the condition and permanent visual loss. Discontinuation of corticosteroids should be the first step in the treatment of CSCR associated with corticosteroid therapy, and the use of immunosuppressive or immunomodulatory drugs may be required to control systemic or ocular inflammatory disease. The prognosis is usually favorable, but persistent visual loss may occur.
    Ocular immunology and inflammation 04/2012; 20(2):76-85. DOI:10.3109/09273948.2011.650776 · 1.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conventional treatment of idiopathic central serous chorioretinopathy (ICSC) consists of argon laser, photodynamic therapy, or observation. However, in cases of atypical bullous ICSC with exudative detachment preventing any laser therapy, a surgical approach with external drainage of fluid has been performed. We present a case of ICSC with persistent macula involving exudative retinal detachment without evidence of uveitis that responded favorably to internal drainage by vitrectomy along with a scleral buckle placement. Our case, treated with internal drainage, also demonstrated successful long-term reattachment of the serous retinal detachment without any additional complications from the surgery.
    International Ophthalmology 02/2013; DOI:10.1007/s10792-013-9731-9 · 0.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This report describes the use of pars plana vitrectomy (PPV) in the management of a patient with a serous retinal detachment (SRD) secondary to lupus choroidopathy. Surgery was performed after anti-inflammatory treatments and laser photocoagulation failed to resolve the condition. The patient's vision improved, and the subretinal fluid has not reaccumulated at 5 years postoperatively. The high viscosity of the subretinal fluid observed during the procedure may account for the persistence of the SRD despite control of inflammation. PPV surgery can be considered as a treatment option for patients with lupus-related SRD when anti-inflammatory medications are not successful and the subretinal fluid does not reabsorb independently. [Ophthalmic Surg Lasers Imaging Retina. 2013;44:502-504.].
    09/2013; 44(5):502-4. DOI:10.3928/23258160-20130909-17
Show more

Preview (2 Sources)

Available from